ArticleWorld journal of urology2025

Piperlongumine enhances the antitumor efficacy of PD-1 inhibitors by inducing immunogenic cell death in prostate cancer cells.

Zhangjie Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.